IP & IT News
Elon Musk reaches deal over tweets about taking Tesla private
BBC News – 30 September
The Securities and Exchange Commission (SEC) has forced Elon Musk to step down as chair of Tesla after allegations of securities fraud. The decision follows tweets Musk posted about taking the firm private, causing shares to initially rise. Musk has been banned from his position as chair of Tesla for three years but will remain the CEO.
Major security flaw in Tory conference app reveals users' data
The Guardian – 29 September
The data of hundreds of attendees of the Conservative party conference 2018 in Birmingham has been compromised following a major flaw in the conference mobile phone app. Anyone could use MPs email addresses and login to the app, altering personal details of MPs and making them public.
Planning for “No Deal” – IP Rights after Brexit
Reddie & Grose – 25 September
The Government has released a series of notices providing guidance on intellectual property rights should the UK receive a ‘no deal’ Brexit. Reddie & Grose discuss these notices in detail, but granted European Union trade marks, registered designs, and unregistered designs will automatically be converted into an IP right which covers the remaining EU states and will be enforceable via a similar right in the UK.
EU warns Facebook it faces sanctions over 'misleading' T&Cs
The Guardian – 20 September
Věra Jourová, the EU commissioner in charge of consumer protection, has warned Facebook it will face sanctions over its ‘misleading’ terms and conditions, unless they are changed before the end of the year. Jourová has been in discussions with Facebook over their terms and conditions for the last two years.
Gilead to lose protections for HIV drug
Out Law – 19 September
The High Court in London has ruled that Gilead, a pharmaceuticals company, will be losing its intellectual property rights for an HIV drug it has developed. Mr Justice Arnold ruled that the company was not entitled to a supplementary protection certificate (SPC) as its patent claims were not specific to a product.